Barbara Mantel is an NBC News contributor. She is also the topic leader for freelancing at the Association of Health Care Journalists, writing blog posts, tip sheets and market guides, as well as producing and hosting websites. Barbara’s work has appeared in CQ Researcher, AARP, Undark, Next Avenue, Medical Economics, Healthline, Today.com, NPR and The New York Times.
A nasal spray version of esketamine was more effective for depression that is resistant to treatment than a more commonly used drug, research published Wednesday in The New England Journal of Medicine found. Esketamine is a more potent form of ketamine, an anesthetic that doctors have used for many years to treat depression.
Amit Anand, a professor of psychiatry at Harvard Medical School and a director of translational clinical trials at Brigham and Women’s Hospital in Boston. “The bottom line is that better treatments need to be developed,” said Anand, who researches ketamine but was not involved with the new paper. That not all patients who achieved remission at week eight remained in remission by week 32 is not surprising, Grunebaum said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Nasal spray recall: 3 types recalled over potential for ‘life-threatening’ contaminationThree types of nasal spray rinses are being recalled over concerns of the possibility for “life-threatening” contamination.
Lire la suite »
Nasal sprays recalled because they may be contaminated with bacteriaBiomic Sciences recalled all lots of ION Sinus Support, ION Biome Sinus and Restore Sinus Spray on Sept. 29, 2023.
Lire la suite »
Emma Watson Swears by These Nasal Swabs to Stay HealthyThese soothing nasal swabs help alleviate allergy and cold symptoms to give you sinus relief — details here
Lire la suite »
Vaccine via the nasal passage could be the new line of defence against Strep AAs Streptococcus A cases continue to be prevalent, a new nasal vaccine could provide long-term protection from the deadly bacteria. The development of a Strep A vaccine which is currently in Phase 1 clinical trials in Canada and quickly advancing to Phase 2 efficacy trials.
Lire la suite »
Recall alert: Sinus sprays that could cause ‘life-threatening’ reactions recalledThe nasal sprays were recalled because they may have been contaminated.
Lire la suite »
Cowboys star blasts ‘fraudulent’ NBC analyst who trashed Jets’ Zach WilsonJets QB Zach Wilson was harshly criticized by NBC analyst
Lire la suite »